The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Thermo Fisher Scientific
Complexity in sterile injectables development and manufacturing continues to rise—driven not only by formulation and delivery challenges, but also by industry shifts such as the growing demand for orphan drugs for rare diseases and the rapid adoption of advanced delivery systems like autoinjectors and on-body wearables.
Biotech and pharma companies must adapt quickly to meet patient demands, making the choice of the right contract development and manufacturing organization (CDMO) essential.
Download our infographic to uncover 10 key challenges in steriles manufacturing and see how an experienced, end-to-end CDMO partner like Thermo Fisher Scientific can help. With industry-leading expertise and hundreds of NDA approvals supported, we can help speed up your path to IND authorization and first-in-human clinical trials.
Download the infographic to learn more.
